1. Home
  2. GKOS vs LBRDK Comparison

GKOS vs LBRDK Comparison

Compare GKOS & LBRDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$100.96

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Liberty Broadband Corporation Class C

LBRDK

Liberty Broadband Corporation Class C

HOLD

Current Price

$49.44

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
LBRDK
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
LBRDK
Price
$100.96
$49.44
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
$133.07
N/A
AVG Volume (30 Days)
577.7K
964.4K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.34
N/A
Revenue Next Year
$27.46
$109.28
P/E Ratio
N/A
$10.10
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$42.10
52 Week High
$130.23
$104.00

Technical Indicators

Market Signals
Indicator
GKOS
LBRDK
Relative Strength Index (RSI) 37.84 42.90
Support Level $94.92 $47.49
Resistance Level $104.66 $50.21
Average True Range (ATR) 4.02 1.74
MACD -0.71 -0.56
Stochastic Oscillator 22.45 15.13

Price Performance

Historical Comparison
GKOS
LBRDK

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About LBRDK Liberty Broadband Corporation Class C

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

Share on Social Networks: